Matthew Jan Ingrassia

Matthew Ingrassia practices at St. Charles Bend in Bend, Oregon, part of St. Charles Health System.

Matthew Ingrassia's NPI, 1700142122, was assigned on April 10, 2012. Matthew Ingrassia holds Oregon license DO169804.

Matthew Ingrassia's primary practice is St. Charles Bend, at 2500 NE Neff Road, Bend, OR 97701 in Deschutes County. The practice phone is (541) 382-4321.

Matthew Ingrassia's primary practice is St. Charles Bend in Bend, Oregon, part of St. Charles Health System. Matthew Ingrassia is also affiliated with St. Charles Prineville. The medical group on file is St. Charles Health System. Dmand AI also links Matthew Ingrassia to 2 more hospitals, 3 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Ingrassia practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Matthew Ingrassia's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Matthew Ingrassia's licenses on file in 2 states: Oregon and North Carolina.

CMS data shows 1,003 Medicare services from Matthew Ingrassia across 13 procedure codes in 2024, for 358 Medicare patients. Medicare paid $42,947 for them.

CMS counts 358 Medicare patients who saw Matthew Ingrassia in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Ingrassia's median patient age at 71, with 48% women.

In 2024, Matthew Ingrassia wrote 6,583 Medicare Part D claims for 748 patients. 87% of them were for generic drugs. CMS names the drug for 5,828 of them, across 105 drugs with 11 or more claims each, at $485,093 in total drug cost. In 2023, CMS named 7,377 claims across 120 drugs.

Matthew Ingrassia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 6 general payments to Matthew Ingrassia from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $80.